ÂÜÀòÂÒÂ×

Ashwini Pai is an experienced medical affairs professional with a focus on neurology and gene therapy. Currently serving as the Medical Affairs Sickle Cell Disease Lead for bluebird bio since March 2022, Ashwini previously held various roles at Bristol Myers Squibb, including Medical Director and Executive Medical Science Liaison from May 2019 to March 2022, and Senior Regional Medical Liaison prior to that. Ashwini's tenure at Biogen from December 2010 to April 2017 involved roles as Senior Medical Science Liaison and Medical Science Liaison within US Medical Affairs in neurology. Earlier experience includes a post-doctoral fellowship at the University of Washington and a research assistant position at the University of Illinois Chicago. Ashwini holds a Ph.D. in Biopharmaceutical Sciences from the University of Illinois Chicago and a B.S. in Pharmacy from Mumbai University.